Efficacy and safety of dulaglutide 3.0 mg and 4.5 mg versus dulaglutide 1.5 mg in metformin-treated patients with type 2 diabetes in a randomized controlled trial (AWARD-11)
ELI LILLY'S ORAL GLP-1 THERAPY FOUNDAYO (ORFORGLIPRON) IS NOW AVAILABLE FOR WEIGHT LOSS Foundayo is the second oral GLP-1 drug approved for weight management Straight Healthcare April 2026 April 2026 The FDA recently approved Foundayo (orforglipron), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in adults
Real 1:1 support changes behavior
We also like that theyre NSF Certified for Sport, the gold standard in quality and safety testing for dietary supplements
In addition, Semaglutide, another long-acting GLP-1 RA, has demonstrated superior efficacy in lowering blood glucose levels and reducing body weight compared to placebo or Liraglutide
That said, because GLP-1 medications slow gastric emptying, fiber intake should be increased gradually and with adequate hydration
